Scilex Holding Co

Scilex Holding Company, trading on Nasdaq under the ticker SCLX, is a specialty pharmaceutical company focused on non-opioid pain management products. The company reached public markets through a SPAC combination in 2022, having previously operated as a subsidiary of Sorrento Therapeutics before its independent listing. Scilex filed a Form 10-Q with the SEC on August 12, 2022, covering quarterly financials during its transition to a standalone public entity in the specialty pharmaceuticals sector. Its commercial portfolio centers on topical analgesic therapies. For comprehensive filing history, sponsor details, and real-time SPAC analytics on SCLX and hundreds of other listings, sign up for full data access at SpacDesk.